Kernal Biologics
https://www.ycombinator.com/companies/kernal-biologics
Kernal Bio creates mRNA 2.0 therapies that instruct specific cells on how to make their own medicine. Kernal Bio encrypts mRNA’s “message” in a language that only cancer cells understand. These tumor-specific mRNA therapeutics allow precise targeting of cancer cells, without harming normal cells or tissues. They have recently been validated in preclinical tumor models, showing high efficacy and safety as well as durable adaptive immunity. With roots at MIT, Harvard and Biopharma, Kernal’s management team has deep expertise in mRNA therapeutics space. CEO Yusuf Erkul, M.D., M.B.A. is a successful drug hunter whose research at Merck enabled an FDA-approved drug for ovarian cancer. President, Burak Yilmaz, M.S., previously founded Sentegen, a thriving synthetic biology company which commercializes synthetic DNA, RNA, and diagnostic kits for genetic and infectious diseases. VP of BD, Matt Strout, M.D. Ph.D., M.B.A, is a business development executive who led more than $4.5B worth of BD deals at Alexion and AstraZeneca. VP of R&D Manfred is a leader in immuno-oncology, who was most recently Scientific Senior Director at Bristol-Myers Squibb (BMS).
About
- Year Founded: 2016
- Number of Founders: 3
- HQ: Cambridge, Massachusetts, United States
- Domain: kernalbio.com
- Email: kernal@kernalbio.com
- Industries: Pharmaceutical, Biotechnology, Therapeutics
- Tags: biotech, genomics
- Total Funding: 25000000
- Number of Funding Rounds: 6.0
- Last Funding Round Type: Series A
- Last Funding Date: 2022-07-07
- Team Size: 20
- Founder Names: Yusuf Erkul, Cafer Ozdemir, Burak YILMAZ
Related Companies
BEST COMPANIES IN S20
-
Orange Health Labs
50+ contacts
-
BukuWarung
88+ contacts
-
Zip
153+ contacts
-
Spenmo
54+ contacts
-
Statiq.
101+ contacts
-
Justo
23+ contacts
-
inFeedo AI
105+ contacts
-
Flat
19+ contacts
-
Conta Simples
148+ contacts
-
Zuddl
50+ contacts
-
BIK
10+ contacts
-
Fieldguide
60+ contacts
-
Momence
26+ contacts
-
AtoB
53+ contacts
-
Supabase
49+ contacts
SIMILAR YC COMPANIES
-
Kernal Biologics
9+ contacts
-
Gilgamesh Pharmaceuticals
10+ contacts
-
Lendtable
8+ contacts
-
DraftWise
21+ contacts
-
Arpeggio Bio
9+ contacts
-
Probably Genetic
12+ contacts
-
Talus Bio
11+ contacts
-
Future Fields
12+ contacts
-
Mozart Data
18+ contacts
-
Warmly,
13+ contacts
-
Ready
40+ contacts
-
Kingdom Supercultures
15+ contacts
-
Vitable Health
25+ contacts
-
Streamdal
3+ contacts
-
Nabla Bio
8+ contacts
Contacts
Burak Yilmaz
Co-Founder and President
email: burak@kernalbio.com
linkedin: linkedin.com/in/burak-yilmaz-84400730
Manfred Kraus
Vice President, Head of Research and Development Therapeutics
email: manfred@kernalbio.com
linkedin: linkedin.com/in/manfred-kraus-33192b2
Cafer Ozdemir
Director of Convergence Science
email: cafer@kernalbio.com
linkedin: linkedin.com/in/cafer-ozdemir-phd-22822321
Thomas Addison
Process Development Scientist
email: taddison@kernalbio.com
linkedin: linkedin.com/in/tomaddison23
Joe Parrella
Vice President of CMC
email: None
linkedin: linkedin.com/in/joe-parrella-883821143
Mark Krimmer
Associate Researcher
email: None
linkedin: linkedin.com/in/mark-krimmer
Rudy Christmas
Scientist Ii
email: None
linkedin: linkedin.com/in/rudy-christmas-92503532
Isaak Mueller
Scientist
email: None
linkedin: linkedin.com/in/isaak-mueller-956717103
Ryan Landis
Associate Director
email: None
linkedin: linkedin.com/in/ryanlandis7